-
development. Today, we’re a driving force behind innovative therapies that make a lasting difference to millions of patients around the world. In R&D, all of our history and potential comes together in
-
new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment
-
-on proficiency in using pharmacometrics tools including but not limited to NONMEM, R and Phoenix. Understanding of pharmacometric principles and incorporation of M&S strategies. Ability to develop and deliver
-
integrated biopharmaceutical team across External Innovation and Partnering, R&D, Manufacturing and Commercial operations collaborates. With Ipsen’s footprint in Cambridge, as a North America headquarters in
-
fully integrated biopharmaceutical team across External Innovation and Partnering, R&D, Manufacturing and Commercial operations collaborates. With Ipsen’s footprint in Cambridge, as a North America
-
fully integrated biopharmaceutical team across External Innovation and Partnering, R&D, Manufacturing and Commercial operations collaborates. With Ipsen’s footprint in Cambridge, as a North America
-
innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. With a seasoned GI leadership team at the helm, deep
-
history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. With a seasoned GI leadership team